Shigematsu Works Co., Ltd. (TYO:7980)
795.00
+6.00 (0.76%)
Jan 23, 2026, 3:30 PM JST
Shigematsu Works Revenue
Shigematsu Works had revenue of 3.45B JPY in the quarter ending September 30, 2025, with 5.12% growth. This brings the company's revenue in the last twelve months to 14.25B, up 4.41% year-over-year. In the fiscal year ending March 31, 2025, Shigematsu Works had annual revenue of 14.11B with 8.60% growth.
Revenue (ttm)
14.25B
Revenue Growth
+4.41%
P/S Ratio
0.40
Revenue / Employee
36.54M
Employees
390
Market Cap
5.65B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 14.11B | 1.12B | 8.60% |
| Mar 31, 2024 | 13.00B | 120.00M | 0.93% |
| Mar 31, 2023 | 12.88B | 957.00M | 8.03% |
| Mar 31, 2022 | 11.92B | -781.00M | -6.15% |
| Mar 31, 2021 | 12.70B | 1.10B | 9.50% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medius Holdings | 291.70B |
| JMS Co.,Ltd. | 68.14B |
| SEED Co.,Ltd. | 33.55B |
| Medikit | 23.19B |
| Daiken Medical | 10.09B |
| Platz | 8.33B |
| Sincere Co., LTD. | 7.11B |
| KAINOS Laboratories | 4.44B |